Enanta Pharmaceuticals, Inc. - Common Stock — 재무제표 (NASDAQ:ENTA) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 486.13 M438.79 M375.41 M462.27 M376.65 M280.73 M 총 부채 30.55 M39.36 M54.08 M245.54 M247.84 M216.01 M 자본금 총액 455.58 M399.43 M321.33 M216.74 M128.81 M64.72 M 총 부채 및 주주자본 486.13 M438.79 M375.41 M462.27 M376.65 M280.73 M 총부채 —————— 순부채 ——————

뉴스

Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates

Enanta Pharmaceuticals (ENTA) Moves 5.3% Higher: Will This Strength Last?

Enanta Pharmaceuticals, 전략적 파이프라인 발전 공개

Enanta Pharmaceuticals at The Citizens Life Sciences Conference: Strategic Pipeline Advances

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

Enanta earnings beat by $0.39, revenue topped estimates

Enanta Pharmaceuticals, Inc. (ENTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

베어드, 엔안타 제약에 ’시장수익률 상회’ 투자의견 재확인

Baird reiterates Outperform rating on Enanta Pharmaceuticals stock

Enanta, RSV 및 면역학 파이프라인 진전